Paraproteinemic maculopathy can be unilateral. Decreasing the blood immunoglobulin level is the primary goal of therapy for paraproteinemic maculopathy, and this can be achieved by a systemic route. Coexisting diabetes facilitates leakage of immunoglobulins at lower levels than in nondiabetics.
Figure 2 (a) Funduscopy 3 weeks after the injection of bevacizumab (4 mg). Size reduction of the yellowish mass. (b) OCT scan 3 weeks after the injection of bevacizumab (4 mg). Flattening of the serous retinal detachment. (c) B-mode ultrasonography 3 weeks after the injection of bevacizumab (4 mg). Choroidal mass with an extension of 6.4 Â 2.3 mm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.